Sync-Think Inc. is a Palo Alto, California-based developer of eye-tracking technology products led by CEO Ernest Santin. Its core product, EYE-SYNC, records, views, and analyzes eye movements to support assessment of visual tracking impairments and broader brain health. EYE-SYNC features ocular-motor, ocular-vestibular, SCAT 5, and BESS assessments in a rapid, comprehensive format. The technology received FDA clearance in 2016 to record, view, and analyze eye movements. The product is deployed in VR headsets and is used by university athletic departments and medical clinics, including Stanford University and Massachusetts General Hospital. The company plans to use proceeds from the financing to further develop applications related to EYE-SYNC.

Total raised

$4M

Funding rounds

1

Latest round

Series A

Latest activity

Jan 2018